|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM363904247 |
003 |
DE-627 |
005 |
20240410232244.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109813
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1371.xml
|
035 |
|
|
|a (DE-627)NLM363904247
|
035 |
|
|
|a (NLM)37898412
|
035 |
|
|
|a (PII)S1521-6616(23)00576-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Mansour, Rana
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 03.01.2024
|
500 |
|
|
|a Date Revised 10.04.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a BACKGROUND: RASGRP1-deficiency results in an immune dysregulation and immunodeficiency that manifest as autoimmunity, lymphoproliferation, lymphopenia, defective T cell function, and increased incidence of Epstein-Bar Virus infections and lymphomas
|
520 |
|
|
|a OBJECTIVE: To investigate the mechanism of autoimmune hemolytic anemia and infections in a male patient of consanguineous parents from Lebanon
|
520 |
|
|
|a METHODS: Genetic diagnosis was obtained using next generation and Sanger sequencing. Protein expression and phosphorylation were determined by immunoblotting. T and B cell development and function were studied by flow cytometry. Cytokine and immunoglobulin secretions were quantified by enzyme-linked immunosorbent assay
|
520 |
|
|
|a RESULTS: The patient suffered from severe lymphopenia especially affecting the T cell compartment. Genetic analysis revealed a homozygous insertion of adenine at position 1396_1397 in RASGRP1 that abolished protein expression and downstream Ras signaling. T cells from the patient showed severe activation defects resulting in uncontrolled Epstein-Bar Virus-induced B cell proliferation. B cells from the patient were normal
|
520 |
|
|
|a CONCLUSION: This report expands the spectrum of mutations in patients with RasGRP1 deficiency, and provides evidence for the important role RasGRP1 plays in the ability of T cells to control Epstein-Bar Virus-induced B cell proliferation
|
520 |
|
|
|a CLINICAL IMPLICATIONS: Following diagnosis, the patient will be maintained on oral valganciclovir and monitored regularly for Epstein-Bar Virus infections to avoid the development of Epstein-Bar Virus- induced B cell lymphoma. He is also candidate for hematopoietic stem cell transplantation
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Epstein-Bar virus infections
|
650 |
|
4 |
|a Immune dysregulation
|
650 |
|
4 |
|a Immunodeficiency
|
650 |
|
4 |
|a RASGRP1 deficiency
|
650 |
|
4 |
|a T cell function
|
650 |
|
7 |
|a DNA-Binding Proteins
|2 NLM
|
650 |
|
7 |
|a Guanine Nucleotide Exchange Factors
|2 NLM
|
650 |
|
7 |
|a RASGRP1 protein, human
|2 NLM
|
700 |
1 |
|
|a El-Orfali, Youmna
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Saidu, Adam
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Al-Kalamouni, Habib
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mardirossian, Hagop
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hanna-Wakim, Rima
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Abboud, Miguel
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Massaad, Michel J
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 257(2023) vom: 22. Dez., Seite 109813
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:257
|g year:2023
|g day:22
|g month:12
|g pages:109813
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109813
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 257
|j 2023
|b 22
|c 12
|h 109813
|